Colestipol

In the US, Colestipol (colestipol systemic) is a member of the drug class bile acid sequestrants and is used to treat Hyperlipoproteinemia, Hyperlipoproteinemia Type IIa - Elevated LDL and Hyperlipoproteinemia Type IIb - Elevated LDL VLDL.

US matches:

• Colestipol


• Colestipol Granules


• Colestipol Hydrochloride

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C10AC02

CAS registry number (Chemical Abstracts Service)

0026658-42-4

Therapeutic Category

Antilipemic agent, bile acid sequestrant

Chemical Name

Copolymer of diethylenetriamine and 1-chloro-2,3-epoxypropane

Foreign Names

• Colestipolum (Latin)
• Colestipol (German)
• Colestipol (French)
• Colestipol (Spanish)

Generic Names

• Colestipol (OS: BAN, DCF)
• U 26597 A (IS)
• Colestipol Hydrochloride (OS: USAN, BANM)
• Colestipol Hydrochloride (PH: USP 32, BP 2010)

Brand Names

• Cisplatin
  Pfizer, United Kingdom



• Colestid
  Pfizer, Australia; Pfizer, Belgium; Pfizer, Bahrain; Pfizer, Canada; Pfizer, Switzerland; Pfizer, United Kingdom; Pfizer, Israel; Pfizer, Luxembourg; Pfizer, New Zealand; Pfizer, Oman; Pfizer, Portugal; Pfizer, United States



• Colestipol Hydrochloride
  Global, United States; Impax, United States



• Lestid
  Pfizer, Denmark; Pfizer, Finland; Pfizer, Iceland; Pfizer, Norway; Pfizer, Sweden

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.